Sep 12, 2022 | All Posts, Main Blog, Medical Device |
For healthcare marketers, reaching and engaging today’s busy physicians and C-suite executives is more challenging than ever – especially during and post COVID-19. According to the a recent Survey of America’s Physicians, they, are so busy they have no time to...
Aug 27, 2021 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Historically, oral administration has been considered the easiest and most convenient method of drug delivery, as it requires minimal expertise and invasiveness. Although oral delivery works fairly effectively for small-molecule drug products, oral delivery of...
Jul 7, 2021 | All Posts, Controlled Release, Drug Bioavailability, Main Blog, Peptide |
A prodrug is a medication or compound that metabolizes into a pharmacologically active drug after administration, offering opportunities to optimize the pharmaceutical property to improve bioavailability. Approximately 10% of all marketed drugs worldwide can be...
Jun 29, 2021 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Nanomedicines leading the way Nanotechnology offers multiple benefits in treating chronic diseases by site-specific, and target-oriented delivery of medicines. Nano-delivery systems utilized in drug development are very much still relatively new commercial approach....
Mar 13, 2021 | All Posts, Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Given the rise of peptide and protein therapeutics in the pharmaceutical landscape, identifying the right delivery strategies that are patient-friendly and can be used over broad dose ranges has always been important considerations for the discovery and development of...
Mar 6, 2021 | All Posts, BioPharma Marketing, Main Blog, Medical Device |
Beyond the Pill: Sanofi’s Approach to Digital Therapeutics & Driving Improved Outcomes for Patients “In the context of the COVID-19 public health emergency, the use of digital health technologies, including software as a medical device or other digital...
Recent Comments